Pharmacological and clinical aspects of fluvoxamine (Depromel), the first selective serotonin reuptake inhibitor approved for clinical use employed in Japan.
2) Baldessarini RJ: Drugs and the treatment of psychiatric disorders---depression and mania. In Goodman & Gilman's The Pharmacological Basis of Therapeutics 9<SUP>th</SUP>, ed. Edited by Hardman JG and Limbird LE, pp431-459, The McGraw-Hill Co, New York (1996)
3) Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U and Kendler KS: Lifetime and 12-month prevalence of DSM-III-R Psychiatric disorders in the United States. Arch Gen Psychiatry 51, 8-19 (1994)